Sentry Investment Management LLC Has $133,000 Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sentry Investment Management LLC lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 17.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,708 shares of the company’s stock after selling 350 shares during the quarter. Sentry Investment Management LLC’s holdings in GE HealthCare Technologies were worth $133,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Capital Research Global Investors lifted its position in GE HealthCare Technologies by 5.2% during the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after buying an additional 2,647,204 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 9.2% during the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after purchasing an additional 4,107,746 shares during the last quarter. Hotchkis & Wiley Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 9.4% during the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock valued at $426,186,000 after purchasing an additional 471,910 shares during the last quarter. Norges Bank bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $229,052,000. Finally, Goldman Sachs Group Inc. raised its position in GE HealthCare Technologies by 41.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,875,589 shares of the company’s stock worth $145,021,000 after purchasing an additional 550,612 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on GEHC. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research note on Monday. They issued a “neutral” rating and a $90.00 target price for the company. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research report on Tuesday, August 6th. They set a “buy” rating and a $100.00 target price on the stock. Finally, The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target for the company. Six equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average price target of $94.58.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $87.46 on Friday. The stock’s fifty day simple moving average is $82.85 and its 200 day simple moving average is $83.50. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $39.92 billion, a PE ratio of 25.57, a PEG ratio of 3.18 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same quarter in the previous year, the business posted $0.92 EPS. GE HealthCare Technologies’s revenue for the quarter was up .5% on a year-over-year basis. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a $0.03 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Insider Buying and Selling

In other news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.